My watch list  

Duchenne Muscular Dystrophy

News Duchenne Muscular Dystrophy

  • A golden ticket to faster muscle recovery

    Anyone who has ever torn or injured a muscle knows that swelling, redness, and pain soon follow the injury: classic signs of inflammation. Inflammation is the body’s natural response to promote healing, but prolonged, excess inflammation in the muscles can contribute to the progression of chronic di more

  • Drug pair slows progression of muscular dystrophy in animal models

    A pair of protein-inhibiting compounds is effective at slowing the progression of a form of muscular dystrophy in animal models, a group of University of Florida Health researchers has found. The compounds of this novel drug class are particularly intriguing for use by Duchenne muscular dystrophy pa more

  • FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

    The U.S. Food and Drug Administration approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping, whi more

All news on duchenne muscular dystrophy

Publications Duchenne Muscular Dystrophy

All publications on duchenne muscular dystrophy

Duchenne muscular dystrophy

Duchenne muscular dystrophy Duchenne muscular dystrophy (DMD) is a form of muscular dystrophy that is characterized by decreasing muscle mass and progressive loss of muscle function in male children. This disorder is caused by a mutation in a sp ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE